Purpose: To evaluate the use of data from population-based surveys such as the National Health and Nutrition Examination Survey (NHANES) for external adjustment for confounders imperfectly measured in health care databases in the United States.
Methods: Our example study used Medicaid Analytic eXtract (MAX) data to estimate the relative risk (RR) for prenatal serotonin-norepinephrine reuptake inhibitors (SNRIs) exposure and cardiac defects. Smoking and obesity are known confounders poorly captured in databases. NHANES collects information on lifestyle factors, depression, and prescription medications. External adjustment requires information on the prevalence of confounders and their association with SNRI use; which was obtained from the NHANES. It also requires estimates of their association with the outcome, which were based on the literature and allowed us to correct the RR using sensitivity analyses.
Results: In MAX, the RR for the association between prenatal SNRI exposure and cardiac defects was 1.51 unadjusted and 1.20 adjusted for measured confounders and restricted to women with depression. In NHANES, among women of childbearing age with depression, the prevalence of smoking was 60.2% (95% Confidence Interval 43.2, 74.3) for SNRI users and 44.1% (39.6, 48.8) for nonusers of antidepressants. The corresponding estimates for obesity were 59.2% (43.2, 74.3) and 40.5% (35.9, 45.0), respectively. If the associations between smoking and obesity with cardiac defects are independent from each other and from other measured confounders, additional adjustment for smoking and obesity would move the RR from 1.20 to around 1.10.
Conclusion: National surveys like NHANES are readily available sources of information on potential confounders and they can be used to assess and improve the validity of RR estimates from observational studies missing data on known risk factors.
Keywords: NHANES; bias; confounding; external adjustment; pharmacoepidemiology; sensitivity analyses.
© 2019 John Wiley & Sons Ltd.
Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.Pharmacoepidemiol Drug Saf. 2006 May;15(5):291-303. doi: 10.1002/pds.1200. Pharmacoepidemiol Drug Saf. 2006. PMID: 16447304
Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States.Version 2. BMJ. 2013 Aug 21;347:f4877. doi: 10.1136/bmj.f4877. BMJ. 2013. PMID: 23965506 Free PMC article.
Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction.Epidemiology. 2005 Jan;16(1):17-24. doi: 10.1097/01.ede.0000147164.11879.b5. Epidemiology. 2005. PMID: 15613941
Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information.Med Care. 2007 Oct;45(10 Supl 2):S158-65. doi: 10.1097/MLR.0b013e318070c045. Med Care. 2007. PMID: 17909375 Free PMC article. Review.
The United States National Health and Nutrition Examination Survey and the epidemiology of ankylosing spondylitis.Am J Med Sci. 2011 Apr;341(4):281-3. doi: 10.1097/MAJ.0b013e31820f8c83. Am J Med Sci. 2011. PMID: 21358307 Review.
- Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58:323-337.
- Huybrechts KF, Bateman BT, Hernandez-Diaz S. Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy. Pharmacoepidemiol Drug Saf. 2019;28:906-922.
- Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004;148:99-104.
- Palmsten K, Huybrechts KF, Kowal MK, Mogun H, Hernandez-Diaz S. Validity of maternal and infant outcomes within nationwide Medicaid data. Pharmacoepidemiol Drug Saf. 2014;23:646-655.
- Cornfield J, Haenszel W, Hammond EC, Lilienfeld AM, Shimkin MB, Wynder EL. Smoking and lung cancer: recent evidence and a discussion of some questions. J Natl Cancer Inst. 1959;22:173-203.